Dr. Pratima Tripathi is a senior pharmaceutical industry leader with deep expertise in oncology strategy, commercial leadership, and patient-centric access innovation. She serves as Commercial Director – Oncology at Servier India, where she leads the commercial strategy and execution for the company’s oncology portfolio, focusing on expanding access to precision medicines and integrating evidence-based therapies into clinical practice across India. In this role, she works closely with clinicians, policy makers, partners and patient communities to ensure that scientific advances translate into improved outcomes for individuals affected by cancer.

Under her commercial leadership, Servier India has launched and supported initiatives that reinforce its commitment to precision oncology, including affordable biomarker testing programmes that make advanced molecular diagnostics available at subsidised rates — a move aimed at facilitating early and accurate cancer diagnosis that guides treatment decisions and supports improved survival outcomes. She has also been instrumental in positioning innovative oncology therapies within the Indian healthcare landscape, advocating for equitable access and partnering with stakeholders to address barriers that limit timely treatment.

Dr. Tripathi’s professional focus reflects a blend of strategic commercial planning with a mission to drive greater integration of cutting-edge cancer care solutions into routine clinical settings. Through her work, she contributes to Servier’s broader ambition to enhance the impact of oncology care in India, aligning organisational objectives with patient needs across diverse clinical environments.